Please login to the form below

Not currently logged in
Email:
Password:

Simponi Aria

This page shows the latest Simponi Aria news and features for those working in and with pharma, biotech and healthcare.

FDA approves intravenous Simponi for arthritis treatment

FDA approves intravenous Simponi for arthritis treatment

FDA approves intravenous Simponi for arthritis treatment. J&J says Simponi Aria will offer less frequent dosing schedule than subcutaneous version. ... of 30 minutes with a dosing regimen of every 8 weeks,” said Rob Bazemore, president of Janssen

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
SpotMe

SpotMe is the leading technology and service provider of enterprise engagement platforms with a focus on live events, virtual and...

Latest intelligence

The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...
Unique forum will unite NHS and industry to drive innovation
HSJ Life Sciences Forum will explore key NHS challenges and debate future of medicines, by Sarah Eglington, Client Services Director at Wilmington Healthcare...

Infographics